Search research articles
Contact Us
Filters
Showing results (131-140 of 135) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 135 results.
Nature
|
August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Nature
|
January 20, 2021
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Physical Review Letters
|
August 29, 2014
First measurements of spin-dependent double-differential cross sections and the Gerasimov-Drell-Hearn Integrand from 3He(γ,n)pp at incident photon energies of 12.8 and 14.7 MeV
G Laskaris, Q Ye, B Lalremruata, et al.
Nature Communications
|
December 5, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
Wei Chen, Kristin R Tompkins, Ian W Windsor, et al.
NPJ Vaccines
|
November 20, 2024
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 135) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 135 results.
Nature
|
August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Nature
|
January 20, 2021
Publisher Correction: Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
Mark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Physical Review Letters
|
August 29, 2014
First measurements of spin-dependent double-differential cross sections and the Gerasimov-Drell-Hearn Integrand from 3He(γ,n)pp at incident photon energies of 12.8 and 14.7 MeV
G Laskaris, Q Ye, B Lalremruata, et al.
Nature Communications
|
December 5, 2025
Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
Wei Chen, Kristin R Tompkins, Ian W Windsor, et al.
NPJ Vaccines
|
November 20, 2024
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine
Kayvon Modjarrad, Ye Che, Wei Chen, et al.
Page
of 14